Mr. Davinder Singh Brar joined the Board of Mphasis in April 2004 and is the Chairman of the Board effective 11 December 2015.
Mr. Brar graduated with a Bachelor of Engineering (Electrical) degree from Thapar Institute of Engineering and Technology, Patiala an
has a Master’s in Business Administration with top rank (Gold Medal) from the Faculty of Management Studies, University of Delhi.
Mr. Brar started his career in 1974 with The Associated Cement Companies Limited (ACC) and has been associated with the
Pharmaceutical Industry for over four decades. He spent a major part of this period (1977 – 2004) with Ranbaxy Laboratories Limited
and became the CEO and Managing Director in 1999. Mr. Brar started his entrepreneurial journey in 2004 with GVK Biosciences (Now
Aragen Life Sciences Private Limited) – a leading contract research organization (CRO) providing discovery and development services to
global life sciences companies.
Mr. Davinder Singh Brar, Chairman
Mr. Brar holds Board positions in Maruti Suzuki India Limited, Wockhardt Limited, Punjab Innovation Mission, EPL Limited
(Chairman of the Board), Konnect Agro Private Limited, Mountain Trail Foods Private Limited and acts as a senior advisor to private
equity and venture funds. He is currently the Chairman of Aragen Life Sciences Private Limited and Excelra Knowledge Solutions Pvt. Ltd.
He is also a member of the Advisory Board of the USA-India Chamber of Commerce (USAIC).
Mr. Brar was a director of Reserve Bank of India (RBI) and a member of the inspection and audit sub-committee of the Central Board
of Directors of RBI. He has also served as a member of the Board of National Institute of Pharmaceutical Education and Research
(NIPER), Punjab and as a member of the Board of Governors of the Indian Institute of Management, Lucknow. He was associated with
Confederation of Indian Industry (CII) where he Chaired CII’s Indian MNC Council and with Federation of Indian Chambers of Commerce
and Industry (FICCI) in the past.
Mr. Brar was a member of the Prime Minister’s task force on pharmaceuticals and knowledge-based industries which drafted the
blueprint for the growth and global expansion of Indian Pharmaceutical Industry. For his service and contribution to the pharmaceutical
industry, Mr. Brar was honoured with the Dean’s Medal from the Tufts University School of Medicine, U.S.A. in 2004. The Federation of
Asian Biotech Associations (FABA) conferred on Mr. Brar the “FABA Special Award 2011” for his contribution to the biopharma sector.
